Considering that α-synuclein positivity is associated with increased risk of subsequent diagnosis of PD and DLB, its detection might represent a potential prodromal marker of these neurodegenerative disorders and a precious target in the neuroprotective trials [156]. The gene discussed is SNCA; the disease is Parkinson disease.